Publications by authors named "S E Kalluvya"
Article Synopsis
- Cardiovascular disease (CVD) is a leading cause of premature death among people living with HIV (PLWH), especially in resource-limited settings like Sub-Saharan Africa.
- A study analyzed cardiovascular health profiles of 995 participants (492 PLWH and 503 HIV-uninfected) in Mwanza, Tanzania, using modified definitions and Poisson regressions.
- While PLWH showed better metrics in body mass index, blood pressure, and cholesterol, they had higher smoking rates and lower physical activity, indicating that CVD prevention efforts should prioritize smoking cessation and increasing physical activity levels.
Anemia is common among people living with HIV (PLWH), particularly in Africa. Outcomes for PLWH on modern antiretroviral therapy (ART) regimens are not well documented. We conducted an observational study to determine the outcomes and predictors of anemia after ART initiation in Tanzania.
View Article and Find Full Text PDFThere is an increased risk for tuberculosis (TB) infection and disease progression in prison settings. TB prevalence in prisons in low- and middle-income countries have been measured to be up to 50 -times higher than in the general population. The aim of the study was to perform active TB screening and estimate the burden of TB in central prisons in Tanzania mainland.
View Article and Find Full Text PDFArticle Synopsis
- Hyperuricemia, a condition marked by high uric acid levels, is linked to worsening diabetes outcomes and was studied in patients with type 2 DM in Mwanza, Tanzania to determine its prevalence and related factors.
- The study included 360 participants (59.7% female) with an average age of 61 years and found a 44.4% prevalence of hyperuricemia, with many patients also experiencing poor diabetes control and other comorbidities like hypertension and obesity.
- Key factors associated with hyperuricemia included being female, having a high body mass index, and chronic kidney disease, emphasizing the need for regular screening in this population to improve health outcomes.
Background: Prospective data on the effectiveness of resistance testing in informing treatment decisions and outcomes in with first-line failure in these settings is limited. This study aimed to assess the virological impact of HIV drug-resistance testing in patients with virological failure in Tanzania.
Methods: Participants were randomly assigned to either the control or the experimental group.